Loading ChartRhythms
Preparing market rhythm analysis...
Preparing market rhythm analysis...
Full Rhythm Report
AFL • Stock • Financials / Life & Health Insurance
Current Price
$111.54
+0.32%
Provider quote snapshot • As of 2026-10-02T20:00:00.000Z
Back to stock pageCross-Horizon Read
AFL's evidence points supportive across the available windows.
Generated 2026-10-05T10:50:00.000Z • Evidence 10d05e9e
Price Data
A quote snapshot is available, but historical price data is not connected yet.
ChartRhythms displays a price chart only when real historical time-series data is available. No estimated or synthetic chart is shown.
0–3 days
Supporting articles
0
Opposing articles
0
Neutral articles
0
Confidence basis
Supporting evidence
No supporting articles were found in this window.
Opposing evidence
No opposing articles were found in this window.
Catalysts
No specific catalysts were identified in this window.
Risks
No specific risk mentions were identified in this window.
Next proof points
• Additional dated, company-specific coverage in the 0–3 days window.
Strengthens if
• Supporting evidence (0) grows relative to opposing evidence (0) in this window.
• No evidence is available for this window is resolved.
Weakens if
• Opposing evidence (0) grows relative to supporting evidence (0) in this window.
Sources in this window (0)
No sources are available for this window yet.
4–21 days
Supporting articles
0
Opposing articles
0
Neutral articles
0
Confidence basis
Supporting evidence
No supporting articles were found in this window.
Opposing evidence
No opposing articles were found in this window.
Catalysts
No specific catalysts were identified in this window.
Risks
No specific risk mentions were identified in this window.
Next proof points
22–90 days
The 22–90 days evidence set currently reads slightly bullish.
Supporting articles
2
Opposing articles
1
Neutral articles
12
Confidence basis
Supporting evidence
• Here's Why Investors Should Stay Invested in Aflac Stock for Now
• Is Aflac (AFL) Still Reasonable After A 143% Five Year Run?
Opposing evidence
• Aflac (AFL) Q2 2026 Earnings Call Transcript
Help improve this analysis
This feedback is saved locally for the MVP. Later, ChartRhythms can use this feedback to improve the strategy engine.
Important:
ChartRhythms provides source-based market summaries for research and informational purposes only. This is not financial advice and not a recommendation to buy, sell, or hold any security.
• Additional dated, company-specific coverage in the 4–21 days window.
Strengthens if
• Supporting evidence (0) grows relative to opposing evidence (0) in this window.
• No evidence is available for this window is resolved.
Weakens if
• Opposing evidence (0) grows relative to supporting evidence (0) in this window.
Sources in this window (0)
No sources are available for this window yet.
Catalysts
• Wolfe Research Initiates Coverage On Aflac with Underperform Rating, Announces Price Target of $103
• 5 Revealing Analyst Questions From Aflac’s Q2 Earnings Call
• Aflac (AFL) Q2 2026 Earnings Call Transcript
• Keefe, Bruyette & Woods Maintains Market Perform on Aflac, Raises Price Target to $125
• AFL Q2 Deep Dive: Japan Product Refresh and U.S. Group Momentum Offset Sales Decline
Risks
• Aflac (AFL) Q2 2026 Earnings Call Transcript
• Is Aflac (AFL) Still Reasonable After A 143% Five Year Run?
Next proof points
• Continued coverage in the 22–90 days window confirming the current read.
Strengthens if
• Supporting evidence (2) grows relative to opposing evidence (1) in this window.
• The most recent evidence in this window is not very fresh is resolved.
Weakens if
• Opposing evidence (1) grows relative to supporting evidence (2) in this window.
Showing 8 of 15 sources
Wolfe Research Initiates Coverage of Aflac (AFL) with Underperform Recommendation
Fintel • 2026-08-20 • Neutral
Open via Finnhub →Wells Fargo Maintains Equal-Weight on Aflac, Raises Price Target to $122
Benzinga • 2026-08-19 • Neutral
Open via Finnhub →Wolfe Research Initiates Coverage On Aflac with Underperform Rating, Announces Price Target of $103
Benzinga • 2026-08-19 • Neutral
Open via Finnhub →5 Revealing Analyst Questions From Aflac’s Q2 Earnings Call
Yahoo • 2026-08-15 • Mixed
Open via Finnhub →Here's Why Investors Should Stay Invested in Aflac Stock for Now
Yahoo • 2026-08-14 • Bullish
Open via Finnhub →Keefe, Bruyette & Woods Maintains Market Perform on Aflac, Raises Price Target to $125
Benzinga • 2026-08-11 • Neutral
Open via Finnhub →AFL Q2 Deep Dive: Japan Product Refresh and U.S. Group Momentum Offset Sales Decline
Yahoo • 2026-08-11 • Mixed
Open via Finnhub →